Continuous improvement in primary debulking surgery for advanced ovarian cancer: do increased complete gross resection rates independently lead to increased …
JH Tseng, RA Cowan, Q Zhou, A Iasonos, M Byrne… - Gynecologic …, 2018 - Elsevier
Objectives To assess complete gross resection (CGR) rates and survival outcomes in
patients with advanced ovarian cancer who underwent primary debulking surgery (PDS) …
patients with advanced ovarian cancer who underwent primary debulking surgery (PDS) …
Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer
C Polen-De, P Fadadu, AL Weaver… - International Journal of …, 2022 - ijgc.bmj.com
Background Sarcopenia is prevalent among older patients with cancer and is associated
with poor outcomes. Objective To explore the relationship between muscle mass, quality …
with poor outcomes. Objective To explore the relationship between muscle mass, quality …
Survival outcomes in patients with cervical cancer treated with open versus robotic radical hysterectomy: our surgical pathology interrogation
J Yang, C Mead-Harvey, C Polen-De, P Magtibay… - Gynecologic …, 2020 - Elsevier
Objective To compare the survival outcomes and surgical radicality between women who
underwent open versus robotic radical hysterectomy (RH) for early cervical cancer. Methods …
underwent open versus robotic radical hysterectomy (RH) for early cervical cancer. Methods …
[HTML][HTML] Advanced ovarian cancer patients identify opportunities for prehabilitation: a qualitative study
C Polen-De, C Langstraat, GB Asiedu, A Jatoi… - Gynecologic Oncology …, 2021 - Elsevier
Prehabilitation may modify frailty and increase resilience in a subset of ovarian cancer
patients; however there is low adherence to most programs. Our aim was to investigate …
patients; however there is low adherence to most programs. Our aim was to investigate …
Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer
C Polen-De, S Giri, P Fadadu, A Weaver… - JNCI …, 2023 - academic.oup.com
Data evaluating change in body composition during treatment of advanced cancer are
limited. Here we evaluated computed tomography (CT)–based changes in muscle mass …
limited. Here we evaluated computed tomography (CT)–based changes in muscle mass …
The role of blinded independent radiologic review in ovarian cancer clinical trials: discerning the value
A Loreen, C Polen-De, BJ Monk, AL Jackson… - Gynecologic …, 2021 - Elsevier
Clinical trials are the cornerstone of medical research whereby hypothesis testing leads to
meaningful advancements in care. Clinical trials require close monitoring for patient benefit …
meaningful advancements in care. Clinical trials require close monitoring for patient benefit …
Patient experience and understanding of genetic testing in ovarian cancer
C Polen-De, C Swanson, V Wall, S Rajput… - Gynecologic …, 2021 - Elsevier
Objectives: New advances in ovarian cancer (OC) treatment have solidified the importance
of genetic testing in the management of ovarian cancer. As part of a larger quality …
of genetic testing in the management of ovarian cancer. As part of a larger quality …
Nationwide salpingectomy rates for an indication of permanent contraception before and after published practice guidelines
C Polen-De, K Meganathan, P Lang, S Hohmann… - Contraception, 2019 - Elsevier
Objective To identify the nationwide rate of salpingectomy for permanent contraception
before and after the January 2015 American College of Obstetricians and Gynecologists …
before and after the January 2015 American College of Obstetricians and Gynecologists …
[HTML][HTML] Re-Evaluating Chemotherapy Dosing Strategies for Ovarian Cancer: Impact of Sarcopenia
R Shah, C Polen-De, M McGree, A Fought, A Kumar - Current Oncology, 2023 - mdpi.com
We investigated the impact of sarcopenia on adjuvant chemotherapy dosing in advanced
epithelial ovarian cancer (EOC). The chemotherapy dosing and toxicity of 173 eligible …
epithelial ovarian cancer (EOC). The chemotherapy dosing and toxicity of 173 eligible …
Independent radiologic review in ovarian cancer research
C Polen-De, A Loreen… - Gynecologic …, 2019 - gynecologiconcology-online.net
Objectives: Independent radiologic review (IRR) has been increasingly utilized in ovarian
cancer clinical trials to minimize potential bias when evaluating for progression. Although …
cancer clinical trials to minimize potential bias when evaluating for progression. Although …